Literature DB >> 6057294

Experimental allergic encephalomyelitis in agammaglobulinemic chickens.

M E Blaw, M D Cooper, R A Good.   

Abstract

White Leghorn chickens were subjected to bursectomy and total body irradiation at hatching, thus rendering them agammaglobulinemic. At 4 weeks of age, these chickens and control chickens received lyophilized bovine spinal cord emulsified with complete Freund's adjuvant. Agammaglobulinemic chickens developed the lesions of allergic encephalomyelitis with the same frequency and intensity as the controls. Our findings support the contention that antibodies are not necessary for the development of experimental allergic encephalomyelitis.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6057294     DOI: 10.1126/science.158.3805.1198

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Local production of immunoglobulin in the thyroid gland of obese strain (OS) chickens.

Authors:  K Schauenstein; G Wick
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

2.  [Effect of heterologous antilymphocyte serum on experimental allergic encephalomyelitis].

Authors:  W Land; E Frick; R Roscher; W Brendel; A Baethmann
Journal:  Klin Wochenschr       Date:  1969-06-15

3.  The effect of antisera against rat immunoglobulins on cellular transfer of experimental allergic encephalomyelitiin Lewis rats.

Authors:  W P Richardson; P Y Paterson
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

4.  The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.

Authors:  N K Gonatas; J O Gonatas; A Stieber; R Lisak; K Suzuki; R E Martenson
Journal:  Am J Pathol       Date:  1974-09       Impact factor: 4.307

5.  Cellular events in the induction of experimental allergic encephalomyelitis in rats.

Authors:  L Ortiz-Ortiz; W O Weigle
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.